StockHealthcare · Biotechnology

$ZYME

Zymeworks Inc.

Price · $ZYMEvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $ZYME in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $ZYME in the last 30 days.

Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans - Jazz Pharmaceuticals ( NASDAQ:JAZZ ) , BeOne Medicines ( NASDAQ:ONC ) , Zymeworks ( NASDAQ:ZYME )

Zymeworks Inc. ( NASDAQ:ZYME ) stock is surging on Monday, with a session volume of 2.17 million, compared to an average volume of 728.75K, according to Benzinga Pro.

NOV 6·Zacks Commentary

Zymeworks Inc. ( ZYME ) Reports Q3 Loss, Lags Revenue Estimates

Zymeworks (ZYME) delivered earnings and revenue surprises of +13.33% and -2.31%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

OCT 29·Zacks Commentary

Zymeworks ( ZYME ) Upgraded to Strong Buy: Here's What You Should Know

Zymeworks (ZYME) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

via TradingView

News on $ZYME

All news →